Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Spironolactone plus finasteride reduces hirsutism more effectively.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Hormonal therapies are safe and effective for treating adult women's acne.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Intersex frogs have different brain gene activity related to sex and thyroid hormones.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Left-handed men experience more sexual side effects from finasteride treatment.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Certain extracts from Curcuma aeruginosa Roxb. and germacrone can boost the skin's absorption of minoxidil, a hair growth promoter, making it more effective.

Testosterone increases hamster hair growth; cyproterone acetate reduces it.